Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial
Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial
复制标题
腺病毒介导的血管内皮生长因子基因转移治疗严重肢体缺血:I 期试验的安全性结果
作者:
E. Mohler;S. Rajagopalan;J. Olin;J. Trachtenberg;H. Rasmussen;R. Pak;R. Crystal
Critical limb ischemia (CLI) is typifi ed by rest pain and/or tissue necrosis secondary to advanced peripheral arterial disease (PAD) and is characterized by diminution in limb per-fusion at rest. We tested the safety of an angiogenic strategy with CI-1023 (AdGV VEGF121.10), a replication-defi cient adenovirus encoding human vascular endothelial growth factor isoform 121 in patients with CLI as part of a phase I trial. Fifteen subjects >35 years of age with CLI and angiographic disease involving the infra-inguinal vessels underwent intramuscular injection of CI-1023 (4 3 108 to 4 3 1010 particle units, n = 13) or placebo (n = 2). All of the patients tolerated the injection well and there were no serious complications related to the procedure. Transient edema was noted in one patient. A total of 79 adverse events were reported over the course of one year. One death (day 136) and one malignancy (day 332) occurred in the CI-1023 group. CI-1023 appears to be well tolerated and safe for single-dose administration in patients with critical limb ischemia due to PAD. Further studies are needed to determine the efficacy of this form of therapeutic angiogenesis.
登录
查看更多内容
影响因子:
4.2
作者:
Rauh,G;Pieczek,A;Irwin,W;Schainfeld,R;Isner,JM
通讯作者:
Isner,JM
影响因子:
4.2
作者:
Harvey, BG;Maroni, J;Crystal, RG
通讯作者:
Crystal, RG
影响因子:
37.8
作者:
Baumgartner, I;Pieczek, A;Isner, JM
通讯作者:
Isner, JM
DOI:
10.1152/ajpheart.1994.267.4.h1263
发表时间:
1994
期刊:
The American journal of physiology
影响因子:
--
作者:
Bauters,C;Asahara,T;Zheng,LP;Takeshita,S;Bunting,S;Ferrara,N;Symes,JF;Isner,JM
通讯作者:
Isner,JM